Jérôme Cros

37PUBLICATIONS
141CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Oct 31, 2026
ANO6-mediated trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer cell growth and immune suppression.

|Sep 27, 2026
Clinical application of digital pathology in small intestinal neuroendocrine tumours: proposal of a new G0 category.

|Aug 03, 2026
Impact of Tumor Genomic Profile on Adjuvant Chemotherapy Efficacy in Resected Pancreatic Adenocarcinoma: Results From the PRODIGE-24/CCTG PA6 Study.

|Jul 27, 2026
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

|Apr 29, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer.

|Apr 22, 2026
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer.

Pageof 7

Frequent Collaborators

10 joint publications

Remy Nicolle

8 joint publications

Louis de Mestier

5 joint publications

Jean-Baptiste Bachet

5 joint publications

Jean-François Emile